Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of Thalidomide Plus Dexamethasone Compared With Dexamethasone As Initial Therapy for Newly Diagnosed Multiple Myeloma

PURPOSE: The long-term impact of thalidomide plus dexamethasone (thal/dex) as primary therapy for newly diagnosed multiple myeloma (MM) is unknown. The goal of this study was to compare thalidomide plus dexamethasone versus placebo plus dexamethasone (placebo/dex)as primary therapy for newly diagnos...

Full beskrivning

Sparad:
Bibliografiska uppgifter
Huvudupphovsmän: Rajkumar, S. Vincent, Rosiñol, Laura, Hussein, Mohamad, Catalano, John, Jedrzejczak, Wieslaw, Lucy, Lela, Olesnyckyj, Marta, Yu, Zhinuan, Knight, Robert, Zeldis, Jerome B., Bladé, Joan
Materialtyp: Artigo
Språk:Inglês
Publicerad: 2008
Ämnen:
Article
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC3904367/
https://ncbi.nlm.nih.gov/pubmed/18362366
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2007.14.1853
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk